Current Science

Open Access Open Access  Restricted Access Subscription Access

Medicinal plants with kidney-protecting effect in diabetic nephropathy


Affiliations
1 Department of Medical Biotechnology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, 5th Mile, Tadong, Gangtok 737 102, India
2 Department of Medicine, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, 5th Mile, Tadong, Gangtok 737 102, India
 

Diabetic nephropathy (DN) is a progressive kidney disease, which may often lead to end-stage renal diseases. DN is becoming more prevalent due to the increase in the incidences of diabetes. Controlling blood glucose levels can inhibit DN, but a significant fraction of the diabetic population can develop DN despite glycemic control. Therefore, identification of new drug molecules that can prevent or ameliorate DN by directly acting on the kidney would be a breakthrough in its manage­ment. Medicinal plants offer a vast repository of potential therapeutic agents for several diseases, including diabetes and its complications. A good number of plants have been studied for their kidney-protecting effects on DN. This article summarizes the active compounds and mechanisms by which these plants protect the kidney in diabetic conditions. The majority of the studies are found for animal models. Clinical trials are available only for a few plants, which are also included in this article
User
Notifications
Font Size

  • Chawla, T., Sharma, D. and Singh, A., Role of the renin angiotensin system in diabetic nephropathy. World J. Diabetes, 2010, 1(5), 141–145.

  • Haller, H., Ji, L., Stahl, K., Bertram, A. and Menne, J., Molecular mechanisms and treatment strategies in diabetic nephropathy: new avenues for calcium dobesilate-free radical scavenger and growth factor inhibition. Biomed. Res. Int., 2017, 2017, 1909258.

  • Hussain, S., Jamali, M. C., Habib, A., Hussain, Md. S., Akhtar, M. and Najmi, A. K., Diabetic kidney disease: an overview of prevalence, risk factors, and biomarkers. Clin. Epidemiol. Global Health, 2021, 9, 2–6.

  • Jitraknatee, J., Ruengorn, C. and Nochaiwong, S., Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: a cross-sectional study in primary care practice. Sci. Rep., 2020, 10(1), 6205.

  • Viswanathan, V., Tilak, P. and Kumpatla, S., Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J. Med. Res., 2012, 136(1), 46–53.

  • Gu, H. F., Genetic and epigenetic studies in diabetic kidney disease. Front. Genet., 2019, 10, 507.

  • Vasquez-Rios, G. and Nadkarni, G. N., SGLT2 inhibitors: emerging roles in the protection against cardiovascular and kidney disease among diabetic patients. Int. J. Nephrol. Renovasc. Dis., 2020, 13, 281–296.

  • He, D. et al., Effects of ACE inhibitors and angiotensin receptor blockers in normotensive patients with diabetic kidney disease. Horm. Metab. Res., 2020, 52(5), 289–297.

  • Górriz, J. L. et al., GLP-1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists. J. Clin. Med., 2020, 9(4), 947.

  • Cragg, G. M. and Newman, D. J., Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta, 2013, 1830(6), 3670–3695.

  • Shafi, S., Tabassum, N. and Ahmad, F., Diabetic nephropathy and herbal medicines. Int. J. Phytopharmacol., 2012, 3, 10–17.

  • Khanra, R., Dewanjee, S., Dua, T. K., Sahu, R., Gangopadhyay, M., De Feo, V. and Zia-Ul-Haq, M., Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. J. Transl. Med., 2015, 13, 6.

  • Mir, S. H., Darzi, M. M. and Mir, M. S., Efficacy of Abroma augusta on biochemical and histomorphological features of alloxan-induced diabetic rabbits. Iran. J. Pathol., 2013, 8(3), 153–158.

  • Khanra, R., Bhattacharjee, N., Dua, T. K., Nandy, A., Saha, A., Kalita, J. and Manna, P., Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats. Biomed. Pharmacother., 2017, 94, 726–741.

  • Ziamajidi, N., Nasiri, A., Abbasalipourkabir, R. and Sadeghi Moheb, S., Effects of garlic extract on TNFα expression and oxidative stress status in the kidneys of rats with STZ + nicotinamide-induced diabetes. Pharm. Biol., 2017, 55(1), 526–531.

  • Yuvashree, M., Ganesh, R. N. and Viswanathan, P., Potential application of nanoemulsified garlic oil blend in mitigating the progression of type 2 diabetes-mediated nephropathy in Wistar rats. 3 Biotech., 2020, 10, 272.

  • Huang, H., Zheng, F., Dong, X., Wu, F., Wu, T. and Li, H., Allicin inhibits tubular epithelial-myofibroblast transdifferentiation under high glucose conditions in vitro. Exp. Ther. Med., 2017, 13(1), 254–262.

  • Arellano Buendía, A. S. et al., Immunomodulatory effects of the nutraceutical garlic derivative allicin in the progression of diabetic nephropathy. Int. J. Mol. Sci., 2018, 19(10), 3107.

  • Alok, S., Jain, S. K., Verma, A., Kumar, M., Mahor, A. and Sabharwal, M., Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): a review. Asian Pac. J. Trop. Dis., 2013, 3(3), 242–251.

  • Singla, R. and Jaitak, V., Shatavari (Asparagus racemosus Wild): a review on its cultivation, morphology, phytochemistry and pharmacological importance. Int. J. Pharm. Sci. Res., 2014, 5(3), 742–757.

  • Somani, R., Singhai, A. K., Shivgunde, P. and Jain, D., Asparagus racemosus Willd (Liliaceae) ameliorates early diabetic nephropathy in STZ induced diabetic rats. Indian J. Exp. Biol., 2012, 50(7), 469–475.

  • Wesam, E. M., El-Senosi, Y. A., Aziza, S. A. and Ahmad, S. A., Antidiabetic and kidney protective effect of Asparagus racemosusin alloxan induced diabetic rats. World J. Pharm. Pharm. Sci., 2018, 7(4), 102–114.

  • Godwin, S. E. and Jose, M. A., Effect of Asparagus racemosus against streptozotocin-nicotinamide induced type-2 diabetes mellitus with special reference to diabetic nephropathy in rats. Int. J. Pharm. Chem., 2014, 3(2), 367–375.

  • Joshi, R. K., Asparagus racemosus (Shatawari), phytoconstituents and medicinal importance, future source of economy by cultivation in Uttrakhand: a review. Int. J. Herb. Med., 2016, 4(4), 18–21.

  • Oluwole Busayo, A., Laura, Z., Olufunke Olubusola, D., Oluwafunmike Sharon, A., Luciana, D. and Ezekiel Ademola, C. M., Ameliorative effects of ethanolic leaf extract of Azadirachta indica on renal histologic alterations in streptozotocin-induced diabetic rats. Am. J. Chin. Med., 2011, 39(5), 903–916.

  • Perez Gutierrez, R. M. and de Jesus Martinez Ortiz, M., Beneficial effect of Azadirachta indica on advanced glycation end-product in streptozotocin-diabetic rat. Pharm. Biol., 2014, 52(11), 1435–1444.

  • Chattopadhyay, R. R., Possible mechanism of antihyperglycemic effect of Azadirachtaindica leaf extract: part V. J. Ethnopharmacol., 1999, 67, 373–376.

  • Gupta, S. S., Patchva, S. and Aggarwal, B. B., Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J., 2013, 15(1), 195–218.

  • Huang, J., Huang, K., Lan, T., Xie, X., Shen, X., Liu, P. and Huang, H., Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway. Mol. Cell. Endocrinol., 2013, 365, 231–240.

  • Kim, B. H. et al., Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy. Yonsei Med. J., 2016, 57, 664–673.

  • Lu, M., Yin, N., Liu, W., Cui, X., Chen, S. and Wang, E., Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling. Biomed. Res. Int., 2017, 2017, 1516985.

  • Soetikno, V. et al., Curcumin ameliorates macrophage infiltration by inhibiting NFκ B activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutr. Metab. (London), 2011, 8(1), 35.

  • Soetikno, V. et al., Curcumin attenuates diabetic nephropathy by inhibiting PKCα and PKCβ 1 activity in streptozotocin-induced type I diabetic rats. Mol. Nutr. Food Res., 2011, 55(11), 1655–1665.

  • Jialal, I. and Kaur, H., The role of toll-like receptors in diabetes-induced inflammation: implications for vascular complications. Curr. Diab. Rep., 2012; doi:10.1007/s11892-012-0258-7.

  • Sun, L. N., Yang, Z. Y., Lv, S. S., Liu, X. C., Guan, G. J. and Liu, G., Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation. Int. Immunopharmacol., 2014, 23(1), 236–246.

  • Sun, L. N., Chen, Z. X., Liu, X. C., Liu, H. Y., Guan, G. J. and Liu, G., Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1. Biomed. Pharmacother., 2014, 68(8), 1079–1088.

  • Tu, Q., Li, Y., Jin, J., Jiang, X., Ren, Y. and He, Q., Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells. Pharm. Biol., 2019, 57(1), 778–786.

  • Li, D., Lu, Z., Jia, J., Zheng, Z. and Lin, S., Curcumin ameliorates podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression. Kidney Blood Press. Res., 2013, 38(1), 61–71.

  • Kumar, G. S. and Salimath, P. V., Effect of spent turmeric on kidney glycoconjugates in streptozotocin-induced diabetic rats. J. Diabetes Metab. Disord., 2014, 13, 78.

  • Teoh, S. L., Abd Latiff, A. and Das, S., Histological changes in the kidneys of experimental diabetic rats fed with Momordica charantia (bitter gourd) extract. Rom. J. Morphol. Embryol., 2010, 51(1), 91–95.

  • Araujo, J. A., Zhang, M. and Yin, F., Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front. Pharmacol., 2012, 3, 119.

  • Loboda, A., Damulewicz, M., Pyza, E., Jozkowicz, A. and Dulak, J., Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell. Mol. Life Sci., 2016, 73(17), 3221–3247.

  • Raish, M. et al., Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats. Int. J. Biol. Macromol., 2016, 91, 394–399.

  • Offor, U., Edwin, C. S. N., Ogedengbe, O. O., Jegede, A. I., Peter, A. I. and Onyemaechi, O. A., Renal histopathological and biochemical changes following adjuvant intervention of Momordica charantia and antiretroviral therapy in diabetic rats. Iran. J. Basic Med. Sci., 2019, 22(11), 1359–1367.

  • Kumar, G. S., Shetty, A. K. and Salimath, P. V., Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats. J. Ethnopharmacol., 2008, 115, 276–283.

  • Mardani, S., Nasri, H., Hajian, S., Ahmadi, A., Kazemi, R. and Rafieian-Kopaei, M., Impact of Momordica charantia extract on kidney function and structure in mice. J. Nephropathol., 2014, 3(1), 35–40.

  • Oishi, Y., Sakamoto, T., Udagawa, H., Taniguchi, H., KobayashiHattori, K., Ozawa, Y. and Takita, T., Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Biosci. Biotechnol. Biochem., 2007, 71(3), 735–740.

  • Chen, M., Long, Z., Wang, Y., Liu, J., Pian, H., Wang, L. and Chen, Z., Protective effects of saponin on a hypertension target organ in spontaneously hypertensive rats. Exp. Ther. Med., 2013, 5(2), 429–432.

  • Omodanisi, E. I., Aboua, Y. G. and Oguntibeju, O. O., Assessment of the anti-hyperglycaemic, anti-inflammatory and antioxidant activities of the methanol extract of Moringa oleifera in diabetesinduced nephrotoxic male Wistar rats. Molecules, 2017, 22(4), 439.

  • Al-Malki, A. L. and El Rabey, H. A., The antidiabetic effect of low doses of Moringa oleifera Lam. seeds on streptozotocin induced diabetes and diabetic nephropathy in male rats. BioMed. Res. Int., 2015, 2015, 381040.

  • Villarruel-López, A. et al., Effect of Moringa oleifera consumption on diabetic rats. BMC Complement. Altern. Med., 2018, 18(1), 127.

  • Anjaneyulu, M. and Chopra, K., Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol., 2004, 31(4), 244–248.

  • Cheng, D., Gao, L., Su, S., Sargsyan, D., Wu, R., Raskin, I. and Kong, A. N., Moringa isothiocyanate activates Nrf2: potential role in diabetic nephropathy. AAPS J., 2020, 21, 31.

  • Mestry, S. N., Dhodi, J. B., Kumbhar, S. B. and Juvekar, A. R., Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract. J. Tradit. Complement. Med., 2016, 7, 273–280.

  • Mollazadeh, H., Sadeghnia, H. R., Hoseini, A., Farzadnia, M. and Boroushaki, M. T., Effects of pomegranate seed oil on oxidative stress markers, serum biochemical parameters and pathological findings in kidney and heart of streptozotocin-induced diabetic rats. Ren. Fail., 2016, 38(8), 1256–1266.

  • Arora, S., Bodhankar, S. L., Mohan, V. and Thakurdesai, P. A., Renoprotective effects of reconstructed composition of Trigonella foenum-graecum L. seeds in animal model of diabetic nephropathy with and without renal ischemia reperfusion in rats. Int. J. Pharmacol., 2012, 8, 321–332.

  • Baset, M. et al., Anti-diabetic effects of fenugreek (Trigonellafoenum-graecum): a comparison between oral and intraperitoneal administration – an animal study. Int. J. Funct. Nutr., 2020, 1, 2.

  • Hamden, K., Masmoudi, H., Carreau, S. and Elfeki, A., Immuno-modulatory, beta-cell, and neuroprotective actions of fenugreek oil from alloxan-induced diabetes. Immunopharmacol. Immunotoxicol., 2010, 32(3), 437–445.

  • Jin, Y., Shi, Y., Zou, Y., Miao, C., Sun, B. and Li, C., Fenugreek prevents the development of STZ-induced diabetic nephropathy in a rat model of diabetes. Evid. Based Complement. Altern. Med., 2014, 2014, 259368.

  • Pradeep, S. R., Barman, S. and Srinivasan, K., Attenuation of diabetic nephropathy by dietary fenugreek (Trigonella foenum-graecum) seeds and onion (Allium cepa) via suppression of glucose transporters and renin-angiotensin system. Nutrition, 2019, Nov.Dec., 67–68.

  • Sayed, A. A., Khalifa, M. and Abd el-Latif, F. F., Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: attenuation of diabetic nephropathy in rats. J. Physiol. Biochem., 2012, 68(2), 263–269.

  • Xue, W., Lei, J., Li, X. and Zhang, R., Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity. Nutr. Res., 2011, 31, 555–562.

  • Mowla, A., Alauddin, M., Rahman, M. A. and Ahmed, K., Antihyperglycemic effect of Trigonella foenum-graecum (fenugreek) seed extract in alloxan-induced diabetic rats and its use in diabetes mellitus: a brief qualitative phytochemical and acute toxicity test on the extract. Afr. J. Tradit. Complement. Altern. Med., 2009, 6(3), 255–261.

  • Almomen, S. M., Guan, Q., Liang, P., Yang, K., Sidiqi, A. M., Levin, A. and Du, C., Daily intake of grape powder prevents the progression of kidney disease in obese type 2 diabetic ZSF1 rats. Nutrients, 2017, 9(4), 345.

  • Bao, L., Zhang, Z., Dai, X., Ding, Y., Jiang, Y., Li, Y. and Li, Y., Effects of grape seed proanthocyanidin extract on renal injury in type 2 diabetic rats. Mol. Med. Rep., 2015, 11(1), 645–652.

  • Zhang, Z. et al., Proteomic analysis of kidney and protective effects of grape seed procyanidin B2 in db/db mice indicate MFG-E8 as a key molecule in the development of diabetic nephropathy. Biochim. Biophys. Acta, 2013, 1832(6), 805–816.

  • Al Hroob, A. M., Abukhalil, M. H., Alghonmeen, R. D. and Mahmoud, A. M., Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy. Biomed. Pharmacother., 2018, 106, 381–389.

  • Cui, Y., Shi, Y., Bao, Y., Wang, S., Hua, Q. and Liu, Y., Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4. Biomed. Pharmacother., 2018, 99, 422–430.

  • Rehman, M. U. et al., Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy. Arch. Physiol. Biochem., 2019, 125(3), 201–209.

  • Khajehdehi, P., Pakfetrat, M., Javidnia, K., Azad, F., Malekmakan, L., Nasab, M. H. and Dehghanzadeh, G., Oral supplementation of turmeric attenuates proteinuria, transforming growth factorβ and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized. double-blind and placebo-controlled study. Scand. J. Urol. Nephrol., 2011, 45(5), 365–370.

  • Vanaie, A. et al., Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy. J. Res. Med. Sci., 2019, 24, 77.

  • Soetikno, V., Suzuki, K., Veeraveedu, P. T., Arumugam, S., Lakshmanan, A. P., Sone, H. and Watanabe, K., Molecular understanding of curcumin in diabetic nephropathy. Drug Discov. Today, 2013, 18(15–16), 756–763.

  • Li, M., Wang, W., Xue, J., Gu, Y. and Lin, S., Meta-analysis of the clinical value of Astragalus membranaceousin diabetic nephropathy. J. Ethnopharmacol., 2011, 133(2), 412–419.

  • Musabayane, C. T., Xozwa, K. and Ojewole, J. A., Effects of Hypoxis hemerocallidea (Fisch. & C.A. Mey.) [Hypoxidaceae] corm (African potato) aqueous extract on renal electrolyte and fluid handling in the rat. Ren. Fail., 2005, 27(6), 763–770.

  • Mishra, S., Pani, S. R. and Sahoo, S., Anti-nephrotoxic activity of some medicinal plants from tribal rich pockets of Odisha. Pharmaco. Res., 2014, 6(3), 210–217.

  • Dinda, B., Dinda, S., DasSharma, S., Banik, R., Chakraborty, A. and Dinda, M., Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur. J. Med. Chem., 2017, 131, 68–80.


Abstract Views: 323

PDF Views: 140




  • Medicinal plants with kidney-protecting effect in diabetic nephropathy

Abstract Views: 323  |  PDF Views: 140

Authors

Arundhati Bag
Department of Medical Biotechnology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, 5th Mile, Tadong, Gangtok 737 102, India
Abhiskek Byahut
Department of Medical Biotechnology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, 5th Mile, Tadong, Gangtok 737 102, India
Bidita Khandelwal
Department of Medicine, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, 5th Mile, Tadong, Gangtok 737 102, India

Abstract


Diabetic nephropathy (DN) is a progressive kidney disease, which may often lead to end-stage renal diseases. DN is becoming more prevalent due to the increase in the incidences of diabetes. Controlling blood glucose levels can inhibit DN, but a significant fraction of the diabetic population can develop DN despite glycemic control. Therefore, identification of new drug molecules that can prevent or ameliorate DN by directly acting on the kidney would be a breakthrough in its manage­ment. Medicinal plants offer a vast repository of potential therapeutic agents for several diseases, including diabetes and its complications. A good number of plants have been studied for their kidney-protecting effects on DN. This article summarizes the active compounds and mechanisms by which these plants protect the kidney in diabetic conditions. The majority of the studies are found for animal models. Clinical trials are available only for a few plants, which are also included in this article

References





DOI: https://doi.org/10.18520/cs%2Fv123%2Fi4%2F542-553